Ex-vivo HRMAS of adult brain tumours: Metabolite quantification and assignment of tumour biomarkers

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Wright, Alan J ^a   Fellows, Greg A ^a   Griffiths, John R ^b   Wilson, M ^c,d   Bell, B A ^a   Howe, Franklyn A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; PHOSPHORYLCHOLINE; TUMOR MARKER;

ADULT; ARTICLE; ASTROCYTOMA; BIOCHEMISTRY; BRAIN TUMOR; CANCER GRADING; CONCENTRATION (PARAMETERS); EX VIVO STUDY; GLIOBLASTOMA; GLIOMA; HIGH RESOLUTION MAGIC ANGLE SPINNING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN VIVO STUDY; INFORMATION PROCESSING; LYMPHOMA; MACROMOLECULE; MENINGIOMA; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROGNOSIS; QUANTITATIVE ANALYSIS; ARTIFACT; CLASSIFICATION; DECISION SUPPORT SYSTEM; METABOLISM; METHODOLOGY;

ARTIFACTS; BRAIN NEOPLASMS; DECISION SUPPORT SYSTEMS, CLINICAL; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; TUMOR MARKERS, BIOLOGICAL;

EID: 77955076888     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-66     Document Type: Article

References (53)

1. Howe FA, Opstad KS. 1H MR spectroscopy of brain tumours and masses. NMR Biomed 2003, 16:123-131. 10.1002/nbm.822, 12884355.
2. Tate AR, Underwood J, Acosta DM, Julia-Sape M, Majos C, Moreno-Torres A, Howe FA, Graaf M, Lefournier V, Murphy MM, et al. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 2006, 19:411-434. 10.1002/nbm.1016, 16763971.
3. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006, 58:394-403. 10.1016/j.ejrad.2005.12.032, 16527438.
4. Cheng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, Gonzalez RG. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1997, 94:6408-6413. 10.1073/pnas.94.12.6408, 21063, 9177231.
5. Cheng LL, Anthony DC, Comite AR, Black PM, Tzika AA, Gonzalez RG. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro Oncol 2000, 2:87-95. 10.1215/15228517-2-2-87, 1919517, 11303625.
6. Cheng LL, Chang IW, Louis DN, Gonzalez RG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 1998, 58:1825-1832.
7. Martinez-Bisbal MC, Marti-Bonmati L, Piquer J, Revert A, Ferrer P, Llacer JL, Piotto M, Assemat O, Celda B. 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas. NMR Biomed 2004, 17:191-205. 10.1002/nbm.888, 15229932.
8. Opstad KS, Bell BA, Griffiths JR, Howe FA. Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel. Magn Reson Med 2008, 60:1237-1242. 10.1002/mrm.21496, 18836999.
9. Tugnoli V, Schenetti L, Mucci A, Parenti F, Cagnoli R, Righi V, Trinchero A, Nocetti L, Toraci C, Mavilla L, et al. Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra. Int J Mol Med 2006, 18:859-869.
10. Tzika AA, Cheng LL, Goumnerova L, Madsen JR, Zurakowski D, Astrakas LG, Zarifi MK, Scott RM, Anthony DC, Gonzalez RG, Black PM. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg 2002, 96:1023-1031. 10.3171/jns.2002.96.6.1023, 12066902.
11. Wilson M, Davies NP, Brundler MA, McConville C, Grundy RG, Peet AC. High resolution magic angle spinning 1H NMR of childhood brain and nervous system tumours. Mol Cancer 2009, 8:6. 10.1186/1476-4598-8-6, 2651110, 19208232.
12. Opstad KS, Bell BA, Griffiths JR, Howe FA. Correlation Between in vivo 1H MRS and ex vivo 1H HRMAS Metabolite Concentrations in Human Astrocytomas. ESMRMB 2008, Valencia, Spain.
13. Wilson M, Davies NP, Grundy RG, Peet AC. A quantitative comparison of metabolite signals as detected by in vivo MRS with ex vivo 1H HR-MAS for childhood brain tumours. NMR Biomed 2009, 22:213-219. 10.1002/nbm.1306, 19067434.
14. Opstad KS, Wright AJ, Bell BA, Griffiths JR, Howe FA. Correlations between in vivo (1)H MRS and ex vivo (1)H HRMAS metabolite measurements in adult human gliomas. J Magn Reson Imaging 31:289-297. 10.1002/jmri.22039, 20099340.
15. Liu H, Fang F, Zhu H, Xia SA, Han D, Hu L, Lei H, Liu M. Metabolic changes in temporal lobe structures measured by HR-MAS NMR at early stage of electrogenic rat epilepsy. Exp Neurol 2008, 212:377-385. 10.1016/j.expneurol.2008.04.013, 18538323.
16. Rabeson H, Fauvelle F, Testylier G, Foquin A, Carpentier P, Dorandeu F, van Ormondt D, Graveron-Demilly D. Quantitation with QUEST of brain HRMAS-NMR signals: application to metabolic disorders in experimental epileptic seizures. Magn Reson Med 2008, 59:1266-1273. 10.1002/mrm.21610, 18506844.
17. Ranjan T, Abrey LE. Current management of metastatic brain disease. Neurotherapeutics 2009, 6:598-603. 10.1016/j.nurt.2009.04.012, 19560748.
18. Central Brain Tumour Registry of the United States. , http://www.cbtrus.org/
19. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000, 13:129-153. 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V, 10861994.
20. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993, 30:672-679. 10.1002/mrm.1910300604, 8139448.
21. Reynolds G, Wilson M, Peet A, Arvanitis TN. An algorithm for the automated quantitation of metabolites in in vitro NMR signals. Magn Reson Med 2006, 56:1211-1219. 10.1002/mrm.21081, 17029227.
22. Florian CL, Preece NE, Bhakoo KK, Williams SR, Noble M. Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours. NMR Biomed 1995, 8:253-264. 10.1002/nbm.1940080605, 8732181.
23. Lehnhardt FG, Bock C, Rohn G, Ernestus RI, Hoehn M. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation. NMR Biomed 2005, 18:371-382. 10.1002/nbm.968, 15959923.
24. Nadal L, Leray G, Desbarats C, Darcel F, Bansard JY, Bondon A, de Certaines JD. Proton and phosphorus nuclear magnetic resonance spectroscopy of human brain tumor extracts with automatic data classification: a preliminary study. Cell Mol Biol (Noisy-le-grand) 1997, 43:659-673.
25. Peeling J, Sutherland G. High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms. Magn Reson Med 1992, 24:123-136. 10.1002/mrm.1910240113, 1556919.
26. Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 2002, 15:327-337. 10.1002/nbm.775, 12203224.
27. Griffin JL, Bollard M, Nicholson JK, Bhakoo K. Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR Biomed 2002, 15:375-384. 10.1002/nbm.792, 12357551.
28. Morvan D, Demidem A, Papon J, De Latour M, Madelmont JC. Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Cancer Res 2002, 62:1890-1897.
29. Zektzer AS, Swanson MG, Jarso S, Nelson SJ, Vigneron DB, Kurhanewicz J. Improved signal to noise in high-resolution magic angle spinning total correlation spectroscopy studies of prostate tissues using rotor-synchronized adiabatic pulses. Magn Reson Med 2005, 53:41-48. 10.1002/mrm.20335, 15690501.
30. Brand A, Leibfritz D, Hamprecht B, Dringen R. Metabolism of cysteine in astroglial cells: synthesis of hypotaurine and taurine. J Neurochem 1998, 71:827-832.
31. Lehtimaki KK, Valonen PK, Griffin JL, Vaisanen TH, Grohn OH, Kettunen MI, Vepsalainen J, Yla-Herttuala S, Nicholson J, Kauppinen RA. Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H NMR spectroscopy in vivo, ex vivo, and in vitro. J Biol Chem 2003, 278:45915-45923. 10.1074/jbc.M306209200, 12954643.
32. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009, 37:D603-610. 10.1093/nar/gkn810, 2686599, 18953024.
33. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007, 35:D521-526. 10.1093/nar/gkl923, 1899095, 17202168.
34. Ulrich EL, Akutsu H, Doreleijers JF, Harano Y, Ioannidis YE, Lin J, Livny M, Mading S, Maziuk D, Miller Z, et al. BioMagResBank. Nucleic Acids Res 2008, 36:D402-408. 10.1093/nar/gkm957, 2238925, 17984079.
35. Tosi MR, Fini G, Tinti A, Reggiani A, Tugnoli V. Molecular characterization of human healthy and neoplastic cerebral and renal tissues by in vitro (1)H NMR spectroscopy (review). Int J Mol Med 2002, 9:299-310.
36. Opstad KS, Bell BA, Griffiths JR, Howe FA. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed 2008, 21:677-685. 10.1002/nbm.1239, 18186027.
37. Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson 1999, 141:104-120. 10.1006/jmre.1999.1895, 10527748.
38. Opstad KS, Bell BA, Griffiths JR, Howe FA. An assessment of the effects of sample ischaemia and spinning time on the metabolic profile of brain tumour biopsy specimens as determined by high-resolution magic angle spinning (1)H NMR. NMR Biomed 2008, 21:1138-1147. 10.1002/nbm.1296, 18666093.
39. Cho YD, Choi GH, Lee SP, Kim JK. (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors. Magn Reson Imaging 2003, 21:663-672. 10.1016/S0730-725X(03)00097-3, 12915198.
40. Yue Q, Isobe T, Shibata Y, Anno I, Kawamura H, Yamamoto Y, Takano S, Matsumura A. New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma. Eur Radiol 2008, 18:2901-2911. 10.1007/s00330-008-1079-6, 18641997.
41. Opstad KS, Provencher SW, Bell BA, Griffiths JR, Howe FA. Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS. Magn Reson Med 2003, 49:632-637. 10.1002/mrm.10416, 12652533.
42. Opstad KS, Murphy MM, Wilkins PR, Bell BA, Griffiths JR, Howe FA. Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy. J Magn Reson Imaging 2004, 20:187-192. 10.1002/jmri.20093, 15269942.
43. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000, 21:1645-1649.
44. Kinoshita Y, Kajiwara H, Yokota A, Koga Y. Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study. Neurol Med Chir (Tokyo) 1993, 33:350-359. 10.2176/nmc.33.350, 7689180.
45. Kinoshita Y, Yokota A. Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 1997, 10:2-12. 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N, 9251109.
46. Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 2002, 12:329-340. 10.1007/s003300101037, 11870430.
47. Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, Chen C, Hu Z. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009, 50:217-225. 10.1080/02841850802616752, 19096950.
48. Makino Y, Sakagami H, Takeda M. Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines. Anticancer Res 1999, 19:3125-3132.
49. Terpstra M, Gruetter R. 1H NMR detection of vitamin C in human brain in vivo. Magn Reson Med 2004, 51:225-229. 10.1002/mrm.10715, 14755644.
50. Righi V, Roda JM, Paz J, Mucci A, Tugnoli V, Rodriguez-Tarduchy G, Barrios L, Schenetti L, Cerdan S, Garcia-Martin ML. 1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas. NMR Biomed 2009, 22:629-637. 10.1002/nbm.1377, 19322812.
51. Usenius JP, Vainio P, Hernesniemi J, Kauppinen RA. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994, 63:1538-1543.
52. Mathworks Inc. , http://www.mathworks.com
53. SPSS Inc. , http://www.spss.com